CAS: 1402821-41-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GV-58 REF: TM-T11517CAS: 1402821-41-3 | 97.36% | 52.00 €~1,699.00 € | Mon 16 Dec 24 |
 | GV-58 REF: 7W-GL8315CAS: 1402821-41-3 | - - - | To inquire | Tue 17 Dec 24 |
 | GV-58 REF: 3D-CGC82141CAS: 1402821-41-3 | Min. 95% | To inquire | Mon 27 Jan 25 |
 | GV-58 REF: IN-DA009CI7CAS: 1402821-41-3 | % | - - - | Discontinued product |
GV-58
CAS:1402821-41-3
GV-58 agonizes N/P-Q-type Ca2+ channels (EC50: 7.21/8.81 μM) with 20x less inhibition on CDK kinases.
Formula:
C18H26N6OS
Purity:
97.36%
Color and Shape:
Solid
Molecular weight:
374.5
Ref: TM-T11517
| 1mg | 52.00 € | ||
| 5mg | 146.00 € | ||
| 10mg | 219.00 € | ||
| 25mg | 437.00 € | ||
| 50mg | 631.00 € | ||
| 100mg | 881.00 € | ||
| 500mg | 1,699.00 € | ||
| 1mL*10mM (DMSO) | 161.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
GV-58
CAS:1402821-41-3
GV-58 is a molecule that has been shown to have physiological levels in the brain. …
Formula:
C18H26N6OS
Purity:
Min. 95%
Molecular weight:
374.5 g/mol
Ref: 3D-CGC82141
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
Ref: IN-DA009CI7
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
